Market Research Logo

Pancreatic Cancer Therapy Market to 2025 – Global Analysis and Forecasts By Type (Endocrine Pancreatic Cancer and Exocrine Pancreatic Cancer), Therapy (Biology, Chemotherapy and Others) and Geography

Pancreatic Cancer Therapy Market to 2025 – Global Analysis and Forecasts By Type (Endocrine Pancreatic Cancer and Exocrine Pancreatic Cancer), Therapy (Biology, Chemotherapy and Others) and Geography

The global pancreatic cancer therapy market is expected to reach US$ 4,056.4 Mn in 2025 from US$ 2,011.2 Mn in 2017. The market is estimated to grow with a CAGR of 8.1% from 2018-2025.

The growth of the pancreatic cancer therapy market is primarily attributed to the increase in number of therapies launched in the market. The development of new drugs is thus expected to drive the growth of pancreatic cancer therapy market. For instance, in October 2015, the FDA approved Onivyde drug by Merrimack Pharmaceuticals, Inc. as a part of treatment regimen for advanced pancreatic cancer. Some common side effects associated with chemotherapy drugs include diarrhea and abdominal cramping, fatigue, loss of appetite, change in food taste and others. Cancer cells that are rapidly growing are killed by chemotherapy drugs. However, these drugs travel throughout the body and thus can affect normal and healthy cells adversely. Blood-forming cells in the bone marrow, hair follicles and cell in the mouth, digestive tract, and reproductive system are likely to be affected by chemotherapeutic drugs. The current treatment options available for pancreatic cancer patients only help to extend the patients’ lives by a few months. This demands potential drugs that are able to enhance the effectiveness of chemotherapy drugs. Combination of two or more chemotherapy drugs are a suitable way out to increase the efficacy of the drug as well as proves advantageous in the treatment.

Global pancreatic cancer therapy market, based on the type was segmented into endocrine pancreatic cancer and exocrine pancreatic cancer. In 2017, the exocrine pancreatic cancer segment held the largest share of the pancreatic cancer therapy market, by type. The exocrine pancreatic cancer segment is expected to grow at the fastest rate during the coming years as this cancer is majorly occurring cancer type among the two and thus is expected to have massive patient pool over the forecast years.

Global pancreatic cancer therapy market, based on the therapy was segmented into biologic, chemotherapy and others. In 2017, biologic therapy segment held the largest share of the pancreatic cancer therapy market, by therapy. Moreover, the biologic therapy segment is expected to grow at the fastest rate during the coming years owing to increasing number of novel upcoming immunotherapies as well as targeted cell therapy that treats the cancer without any severe side effects and has number of therapeutic benefits over the conventional chemotherapies.

Some of the major primary and secondary sources for pancreatic cancer therapy included in the report are World Health Organization (WHO), American Society of Clinical Oncology, Pancreatic Cancer Action Network, National Institutes of Health, National Cancer Institute, Scientific American, American Cancer Society and Pancreatic Cancer Research.


1. INTRODUCTION
1.1 SCOPE OF THE STUDY
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
2. GLOBAL PANCREATIC CANCER THERAPY MARKET – KEY TAKEAWAYS
3. GLOBAL PANCREATIC CANCER THERAPY MARKET – MARKET LANDSCAPE
3.1 OVERVIEW
3.2 MARKET SEGMENTATION
3.3 GLOBAL PANCREATIC CANCER THERAPY MARKET – BY TYPE
3.4 GLOBAL PANCREATIC CANCER THERAPY MARKET – BY THERAPY
3.5 GLOBAL PANCREATIC CANCER THERAPY MARKET – BY GEOGRAPHY
3.6 PEST ANALYSIS
3.6.1 North America – PEST Analysis
3.6.2 Europe– PEST Analysis
3.6.3 Asia Pacific– PEST Analysis
3.6.4 Middle East And Africa– PEST Analysis
3.6.5 South and Central America – PEST Analysis
4. GLOBAL PANCREATIC CANCER THERAPY MARKET – KEY MARKET DYNAMICS
4.1 KEY MARKET DRIVERS
4.1.1 Rise in Number of Patients Suffering with Pancreatic Cancer
4.1.2 Increasing Healthcare Expenditures for Pancreatic Drugs
4.1.3 Increase in Number of Therapies Launched in the Market
4.2 KEY MARKET RESTRAINTS
4.2.1 Side Effects of the Therapies
4.2.2 Low Success Rate of Treatments
4.3 KEY MARKET OPPORTUNITIES
4.3.1 Development of Efficient Therapy for Pancreatic Cancer Treatment
4.4 FUTURE TRENDS
4.4.1 Rapid Adoption of Combination Therapy Over Monotherapy
4.5 IMPACT ANALYSIS
5. PANCREATIC CANCER THERAPY MARKET – GLOBAL ANALYSIS
5.1 GLOBAL PANCREATIC CANCER THERAPY MARKET REVENUE FORECASTS AND ANALYSIS
5.2 GLOBAL PANCREATIC CANCER THERAPY MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS
5.3 EXPERT OPINIONS
6. PANCREATIC CANCER THERAPY MARKET ANALYSIS– BY TYPE
6.1 OVERVIEW
6.1.1 Endocrine Pancreatic Cancer
6.1.2 Overview
6.1.3 Global Endocrine Pancreatic Cancer Therapy Market Revenue and Forecasts to 2025 (US$ Mn)
6.1.4 Exocrine Pancreatic Cancer
6.1.4.1 Overview
6.1.4.2 Global Exocrine Pancreatic Cancer Therapy market Revenue and Forecasts to 2025 (US$ Mn)
7. GLOBAL PANCREATIC CANCER THERAPY MARKET ANALYSIS– BY THERAPY
7.1 OVERVIEW
7.2 BIOLOGIC THERAPY
7.2.1 Overview
7.2.2 Global Biologic Therapy Market Revenue and Forecasts to 2025 (US$ Mn)
7.3 CHEMOTHERAPY
7.3.1 Overview
7.3.2 Global Chemotherapy Market Revenue and Forecasts to 2025 (US$ Mn)
7.4 OTHERS
7.4.1 Overview
7.4.2 Global Others Market Revenue and Forecasts to 2025 (US$ Mn)
8. NORTH AMERICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025
8.1 OVERVIEW
8.2 NORTH AMERICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
8.3 NORTH AMERICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)
8.4 NORTH AMERICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN)
8.5 NORTH AMERICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)
8.6 US PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
8.7 US PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
8.7.1 US Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Type (US$ Mn)
8.7.2 US Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Therapy (US$ Mn)
8.8 CANADA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
8.9 CANADA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
8.9.1 Canada Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Type (US$ Mn)
8.9.2 Canada Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Therapy (US$ Mn)
8.10 MEXICO PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
8.11 MEXICO PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
8.11.1 Mexico Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Type (US$ Mn)
8.11.2 Mexico Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Therapy (US$ Mn)
9. EUROPE PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025
9.1 OVERVIEW
9.2 EUROPE PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
9.3 EUROPE PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)
9.4 EUROPE PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN)
9.5 EUROPE PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)
9.6 GERMANY PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
9.6.1 Germany Pancreatic Cancer Therapy Market Revenue and Forecasts To 2025 (US$ Mn)
9.6.2 Germany Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Type (US$ Mn)
9.6.3 Germany Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Therapy (US$ Mn)
9.7 UK PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
9.7.1 UK Pancreatic Cancer Therapy Market Revenue and Forecasts To 2025 (US$ Mn)
9.7.2 UK Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Type (US$ Mn)
9.7.3 UK Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Therapy (US$ Mn)
9.8 FRANCE PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
9.8.1 France Pancreatic Cancer Therapy Market Revenue and Forecasts To 2025 (US$ Mn)
9.8.2 France Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Type (US$ Mn)
9.8.3 France Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Therapy (US$ Mn)
10. ASIA PACIFIC PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025
10.1 OVERVIEW
10.2 ASIA PACIFIC PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
10.3 ASIA PACIFIC PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)
10.4 ASIA PACIFIC PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN)
10.5 ASIA PACIFIC PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN)
10.6 JAPAN PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
10.7 JAPAN PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
10.7.1 Japan Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Type (US$ Mn)
10.7.2 Japan Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Therapy (US$ Mn)
10.8 CHINA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
10.9 CHINA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
10.9.1 China Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Type (US$ Mn)
10.9.2 China Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Therapy (US$ Mn)
10.10 INDIA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
10.11 INDIA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
10.11.1 India Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Type (US$ Mn)
10.11.2 India Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Therapy (US$ Mn)
11. MIDDLE EAST AND AFRICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025
11.1 OVERVIEW
11.2 MIDDLE EAST AND AFRICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
11.3 MIDDLE EAST AND AFRICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)
11.4 MIDDLE EAST AND AFRICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN)
11.5 MIDDLE EAST AND AFRICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN)
11.6 UAE PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
11.7 UAE PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
11.7.1 UAE Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Type (US$ Mn)
11.7.2 UAE Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Therapy (US$ Mn)
11.8 SAUDI ARABIA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
11.9 SAUDI ARABIA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
11.9.1 Saudi Arabia Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Type (US$ Mn)
11.9.2 Saudi Arabia Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Therapy (US$ Mn)
11.10 SOUTH AFRICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
11.11 SOUTH AFRICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
11.11.1 South Africa Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Type (US$ Mn)
11.11.2 South Africa Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Therapy (US$ Mn)
12. SOUTH AND CENTRAL AMERICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025
12.1 OVERVIEW
12.2 SOUTH AND CENTRAL AMERICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
12.3 SOUTH AND CENTRAL AMERICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)
12.4 SOUTH AND CENTRAL AMERICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN)
12.5 SOUTH AND CENTRAL AMERICA PANCREATIC CANCER THERAPY MARKET SHARE, BY COUNTRY (2017 & 2025) (%)
12.6 BRAZIL PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
12.6.1 Brazil Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025 (US$ Mn)
12.6.2 Brazil Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Type (US$ Mn)
12.6.3 Brazil Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Therapy (US$ Mn)
13. PANCREATIC CANCER THERAPY MARKET –INDUSTRY LANDSCAPE
13.1 OVERVIEW
13.2 GROWTH STRATEGIES IN THE PANCREATIC CANCER THERAPY MARKET, 2015-2018
13.3 ORGANIC DEVELOPMENTS
13.3.1 Overview
13.4 ORGANIC GROWTH STRATEGIES IN THE PANCREATIC CANCER THERAPY MARKET, 2015-2018
13.5 CLINICAL TRIALS
13.5.1 Recent Clinical Trials By Players In The Pancreatic Cancer Therapy Market
13.6 PRODUCT APPROVAL
13.6.1 Recent Product Approval By Players In The Pancreatic Cancer Therapy Market
13.7 OTHERS
13.7.1 Other Organic Developments In The Pancreatic Cancer Therapy Market
13.8 INORGANIC DEVELOPMENTS
13.8.1 Overview
13.9 INORGANIC GROWTH STRATEGIES IN THE PANCREATIC CANCER THERAPY MARKET, 2015-2018
13.10 COLLABORATION
13.10.1 Recent Collaborations by Players in the Pancreatic Cancer Therapy Market
13.11 OTHERS
13.11.1 Other Organic Developments In The Pancreatic Cancer Therapy Market
14. PANCREATIC CANCER THERAPY MARKET –KEY COMPANY PROFILES
14.1 ELI LILLY AND COMPANY
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Financial Overview
14.1.4 Product Portfolio
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 F. HOFFMANN-LA ROCHE LTD.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Financial Overview
14.2.4 Product Portfolio
14.2.5 Product Pipeline
14.2.6 SWOT Analysis
14.2.7 Key Developments
14.3 AMGEN INC.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Financial Overview
14.3.4 Product Portfolio
14.3.5 Product Pipeline
14.3.6 SWOT Analysis
14.3.7 Key Developments
14.4 NOVARTIS AG
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Financial Overview
14.4.4 Product Portfolio
14.4.5 Product Pipeline
14.4.6 SWOT Analysis
14.4.7 Key Developments
14.5 CELGENE CORPORATION
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Financial Overview
14.5.4 Product Portfolio
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 MERCK & CO., INC.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Financial Overview
14.6.4 Product Portfolio
14.6.5 Product Pipeline
14.6.6 SWOT Analysis
14.6.7 Key Developments
14.7 PHARMACYTE BIOTECH INC.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Financial Overview
14.7.4 Product Portfolio
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 CLOVIS ONCOLOGY
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Financial Overview
14.8.4 Product Portfolio
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 TEVA PHARMACEUTICAL INDUSTRIES LTD
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Financial Overview
14.9.4 Product Portfolio
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 PFIZER INC.
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Financial Overview
14.10.4 Product Portfolio
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. APPENDIX
15.1 ABOUT THE INSIGHT PARTNERS
15.2 GLOSSARY OF TERMS
15.3 METHODOLOGY
15.3.1 Coverage
15.3.2 Secondary Research
15.3.3 Primary Research
LIST OF TABLES
TABLE 1. NORTH AMERICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)
TABLE 2. NORTH AMERICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN)
TABLE 3. US PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)
TABLE 4. US PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN)
TABLE 5. CANADA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)
TABLE 6. CANADA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN)
TABLE 7. MEXICO PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)
TABLE 8. MEXICO PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN)
TABLE 9. EUROPE PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)
TABLE 10. EUROPE PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN)
TABLE 11. GERMANY PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)
TABLE 12. GERMANY PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN)
TABLE 13. UK PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)
TABLE 14. UK PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN)
TABLE 15. FRANCE PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)
TABLE 16. FRANCE PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN)
TABLE 17. ASIA PACIFIC PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)
TABLE 18. ASIA PACIFIC PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN)
TABLE 19. ASIA PACIFIC PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN)
TABLE 20. JAPAN PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)
TABLE 21. JAPAN PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN)
TABLE 22. CHINA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)
TABLE 23. CHINA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN)
TABLE 24. INDIA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)
TABLE 25. INDIA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN)
TABLE 26. MIDDLE EAST AND AFRICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)
TABLE 27. MIDDLE EAST AND AFRICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN)
TABLE 28. UAE PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)
TABLE 29. UAE PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN)
TABLE 30. SAUDI ARABIA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)
TABLE 31. SAUDI ARABIA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN)
TABLE 32. SOUTH AFRICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)
TABLE 33. SOUTH AFRICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN)
TABLE 34. SOUTH AND CENTRAL AMERICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)
TABLE 35. SOUTH AND CENTRAL AMERICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN)
TABLE 36. BRAZIL PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)
TABLE 37. BRAZIL PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$MN)
TABLE 38. RECENT CLINICAL TRIALS IN THE PANCREATIC CANCER THERAPY MARKET
TABLE 39. RECENT PRODUCT APPROVAL IN THE PANCREATIC CANCER THERAPY MARKET
TABLE 40. OTHER ORGANIC DEVELOPMENTS IN THE PANCREATIC CANCER THERAPY MARKET
TABLE 41. RECENT COLLABORATIONS IN THE PANCREATIC CANCER THERAPY MARKET
TABLE 42. OTHER ORGANIC DEVELOPMENTS IN THE PANCREATIC CANCER THERAPY MARKET
TABLE 43. GLOSSARY OF TERMS, PANCREATIC CANCER THERAPY MARKET
LIST OF FIGURES
FIGURE 1. ASIA PACIFIC PANCREATIC CANCER THERAPY MARKET, REVENUE (US$ MN), BY GEOGRAPHY 2018 & 2025
FIGURE 2. GLOBAL PANCREATIC CANCER THERAPY MARKET BY TYPE, MARKET SHARE (%), 2017
FIGURE 3. GLOBAL PANCREATIC CANCER THERAPY MARKET BY THERAPY, MARKET SHARE (%), 2017
FIGURE 4. GLOBAL PANCREATIC CANCER THERAPY MARKET SEGMENTATION
FIGURE 5. GLOBAL PANCREATIC CANCER THERAPY MARKET SEGMENTATION, BY REGION
FIGURE 6. NORTH AMERICA PEST ANALYSIS
FIGURE 7. EUROPE PEST ANALYSIS
FIGURE 8. ASIA PACIFIC PEST ANALYSIS
FIGURE 9. MIDDLE EAST AND AFRICA PEST ANALYSIS
FIGURE 10. SOUTH AND CENTRAL AMERICA PEST ANALYSIS
FIGURE 11. PANCREATIC CANCER THERAPY MARKET IMPACT ANALYSIS OF DRIVER AND RESTRAINTS
FIGURE 12. GLOBAL PANCREATIC CANCER THERAPY MARKET REVENUE FORECASTS AND ANALYSIS – 2017- 2025
FIGURE 13. GLOBAL PANCREATIC CANCER THERAPY MARKET – BY GEOGRAPHY FORECASTS AND ANALYSIS – 2017- 2025
FIGURE 14. GLOBAL PANCREATIC CANCER THERAPY MARKET BREAKDOWN, BY PRODUCT 2017 & 2025 (%)
FIGURE 15. GLOBAL ENDOCRINE PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 16. GLOBAL EXOCRINE PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 17. GLOBAL PANCREATIC CANCER THERAPY MARKET SHARE, BY THERAPY 2017 & 2025 (%)
FIGURE 18. GLOBAL BIOLOGIC THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 19. GLOBAL CHEMOTHERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 20. GLOBAL OTHERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 21. NORTH AMERICA PANCREATIC CANCER THERAPY MARKET REVENUE, BY COUNTRY (2017) (US$ MN)
FIGURE 22. NORTH AMERICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 23. NORTH AMERICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)
FIGURE 24. US PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 25. CANADA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 26. MEXICO PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 27. EUROPE PANCREATIC CANCER THERAPY MARKET REVENUE, BY COUNTRY (2017) (US$ MN)
FIGURE 28. EUROPE PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 29. EUROPE PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)
FIGURE 30. GERMANY PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 31. UK PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 32. FRANCE PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 33. ASIA PACIFIC PANCREATIC CANCER THERAPY MARKET REVENUE, BY COUNTRY (2017) (US$ MN)
FIGURE 34. ASIA PACIFIC PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 35. JAPAN PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 36. CHINA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 37. INDIA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 38. MIDDLE EAST AND AFRICA PANCREATIC CANCER THERAPY MARKET REVENUE, BY COUNTRY (2017) (US$ MN)
FIGURE 39. MIDDLE EAST AND AFRICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 40. MIDDLE EAST AND AFRICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN)
FIGURE 41. UAE PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 42. SAUDI ARABIA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 43. SOUTH AFRICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 44. SOUTH AND CENTRAL AMERICA PANCREATIC CANCER THERAPY MARKET REVENUE, BY COUNTRY (2017) (US$ MN)
FIGURE 45. SOUTH AND CENTRAL AMERICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 46. SOUTH AND CENTRAL AMERICA PANCREATIC CANCER THERAPY MARKET SHARE, BY COUNTRY (2017 & 2025) (%)
FIGURE 47. BRAZIL PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 48. GROWTH STRATEGIES IN THE PANCREATIC CANCER THERAPY MARKET, 2015-2018
FIGURE 49. ORGANIC GROWTH STRATEGIES IN THE PANCREATIC CANCER THERAPY MARKET, 2015-2018
FIGURE 50. INORGANIC DEVELOPMENTS IN THE PANCREATIC CANCER THERAPY MARKET, 2015-2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report